NCT00002358View on ClinicalTrials.gov

A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV InfectionsChickenpox
Interventions
DRUG

Sorivudine

Trial Locations (1)

06492

Bristol - Myers Squibb Co, Wallingford

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT00002358 - A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV | Biotech Hunter | Biotech Hunter